$IMMB NEWS OUT
Immunotech Laboratories Appoints
$IMMB NEWS OUT >>
Immunotech Laboratories Appoints New Chief Financial Advisor to Strengthen Company's Growth and International Expansion Plan
|
|
|
Immunotech Laboratories, Inc. (PL) (USOTC:IMMB)
Intraday Stock Chart
Today : Thursday 7 February 2013
PASADENA, Calif., Feb. 7, 2013 /PRNewswire/ --
Immunotech Laboratories, Inc. (PINKSHEETS : IMMB )
Immunotech Laboratories, Inc., today announced the appointment of Mr. Valentin Dimitrov to the company Board of Directors as Chief Financial Advisor effective immediately.
Mr. Dimitrov (48) has an impressive professional history in the International Pharmaceutical World along with an impressive background in the formation and management of International Corporations, including the founding member and supervisory Board Chairman of the International Orthodox Bank – (present "Investbank" JSC).
Immunotech Director Bo Linton, further commented Mr. Dimitrov has an extensive knowledge of the Immunotech "IPF" patented technology and has worked alongside the company for several years, assisting with International awareness and potential Clinical Trial progression for the company's Immunotherapy Treatments.Immunotech President Harry Zhabilov commented, "We are very pleased to announce the appointment of Valentin to the Board of Directors and feel he will be a valuable member of our team, and significantly help accelerate the progression of the company towards FDA approval for the 'IPF' technology."
The appointment of Mr. Dimitrov to Immunotech's Board of Directors helps with the potential goal of upgrading the company to the NASDAQ exchange, where a minimum of 5 Board Members are required.
|
About Valentin Lordanov Dimitrov
|
|
|
EDUCATION:
|
|
Kliment Ohridski University
|
Master's degree - Social Pedagogics
|
|
|
|
Kiev State University, Ukraine
|
Bachelor of International Diplomatic Relations
|
|
|
|
SPECIALIZATIONS:
|
|
1995:
|
University of National and World Economy – Sofia - Finances
|
|
|
|
1999:
|
Chemical-technological University - Sofia - Organic chemistry
|
|
|
|
LANGUAGES:
|
English - Fluent , Russian - fluent , German – spoken
|
|
|
PROFESSIONAL BACKGROUND:
|
|
2007-Current:
|
"Vital-Fe" LTD – Distribution of bio-technology and pharmaceutical products – Director
|
|
|
|
2003-Present
|
"Bulgarian Association of Chemical and Fertilizer Industry" – Chairman
|
|
|
|
2002-2003
|
"Chimco Vienna" GmbH – Distributor of chemical and pharmaceutical products – Director
|
|
|
|
1999-2002
|
"CHIMCO" JSC, Vratza - Chemical production plant - Chairman of the Board of Directors
|
|
|
|
1992-1998
|
"Prima Gas" JSC – supply of natural gas – Director
|
|
|
|
1995-1996
|
"International Orthodox Bank" – (present "Investbank" JSC), Founder and member of the Supervisory Board
|
|
|
|
1994-1995
|
"Private Agricultural and Investment Bank" – Member of the Supervisory Board
|
|
|
|
1990-1991
|
"Pharmachem" JSC – pharmaceutical and chemical industry – Director of Department
|
|
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Capricor Under the Spotlight: FDA and SEC Concerns Ah, Capricor Therapeutics, Inc. (NASDAQ: CAPR)—a tale of high stakes and even higher expectations now hanging by a very taut thread. Investors are feeling the heat as the U.S. Food and Drug Administration (FDA) presses pause on Capricor's plans, and the courtroom drama unfolds with a securities class action looming over...
Continue Reading
La Rosa Holdings Reports Impressive Revenue Growth in 2024 Revenue for Q3 2024 Climbs 188% Year-Over-Year to $19.6 Million Aiming for $100 Million in Annualized Revenue by Year-End La Rosa Holdings Corp. (NASDAQ: LRHC) recently disclosed its financial progress, showcasing remarkable growth in the real estate sector. The company revealed that its total revenue witnessed a...
Continue Reading
Understanding Micron Technology's Market Landscape Investors have recently adopted a bearish stance towards Micron Technology (NASDAQ: MU), a trend that calls for attention among market participants. The sizable options activities we've noticed could hint at significant changes brewing in the market for this semiconductor giant. These insights stem from a comprehensive...
Continue Reading
Viz.ai is cutting through the noise in stroke treatment with its revolutionary technology. They’ve recently unveiled some pretty remarkable clinical data showcasing how their product, Viz LVO, can significantly alter the game for patients dealing with large vessel occlusions—an ischemic stroke that typically spells trouble. This isn’t just another tech story; it’s...
Continue Reading
Linda A. Smith Earned Pinnacle Professional Membership Linda A. Smith has made a remarkable mark in the finance sector, and her recent accolade as a Pinnacle Professional Member is a testament to her expertise and commitment. With more than 23 years of experience in finance and budgeting, she brings an impressive array of knowledge and skills to her role. Distinguished...
Continue Reading
